32 Stocks Moving In Wednesday's Mid-Day Session



  • Marin Software Incorporated MRIN shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.
  • Aethlon Medical, Inc. AEMD jumped 49.1% to $5.67 on above-average volume.
  • WiMi Hologram Cloud Inc. WIMI gained 30.3% to $4.60 as the company reported revenue growth of 202.2% year-on-year to $79.9 million for the six months ended June 30, 2021.
  • Discovery, Inc. DISCB shares climbed 27.2% to $60.91. Toyota and Discovery Education launched an initiative inspiring student innovation in STEM.
  • BioCardia, Inc. BCDA jumped 24% to $3.79. Roumell Asset Management reported in a 13D filing a 5.6% stake in BioCardia.
  • Dynavax Technologies Corporation DVAX gained 23.5% to $18.36. Dynavax’s PR highlighted news of Clover Biopharmaceuticals data for COVID-19 vaccine using Dynavax adjuvant.
  • Onconova Therapeutics, Inc. ONTX surged 18.2% to $5.79 as the company reported preliminary data from Phase 1/2a trial of rigosertib plus immune checkpoint inhibitor nivolumab, which are being presented at 3rd Annual RAS Targeted Drug Development Summit.
  • Stitch Fix, Inc. SFIX rose 17.1% to $41.53 after the company reported a surprise profit for its fourth quarter, while sales also surpassed market expectations. The company said it sees Q1 net sales of $560 million to $575mn and adjusted EBITDA of $15 million to $20 million.
  • Celestica Inc. CLS gained 15.6% to $9.31. Platinum Equity agreed to sell PCI Limited to Celestica.
  • Predictive Oncology Inc. POAI rose 15.5% to $1.12.
  • Creatd, Inc. CRTD jumped 15% to $3.2701 after the company announced the debut of its NFT art with a release of six works of NFTs from its 'OG Collection.'
  • Dermata Therapeutics, Inc. DRMA gained 14.6% to $5.73. Brookline recently initiated Dermata Therapeutics coverage with a Buy rating and $14 price target.
  • Inspira Technologies Oxy B.H.N. Ltd. IINN jumped 14.4% to $3.3523 as the company said the ART's device "brain" is to acquire an algorithm enhanced digital platform.
  • Takung Art Co., Ltd. TKAT surged 13.5% to $8.28.
  • Alpine Immune Sciences, Inc. ALPN gained 11.4% to $10.92. Alpine Immune Sciences recently announced a $91 million private placement.
  • Xponential Fitness, Inc. XPOF surged 9.1% to $11.28. Raymond James upgraded Xponential Fitness from Market Perform to Strong Buy and announced a $14 price target.
  • Sasol Limited SSL rose 7% to $16.61. Sasol and Haldor Topsøe highlighted expansion of licensing collaboration to 'grow sustainable synthetic fuels and chemicals globally.'
  • BSQUARE Corporation BSQR rose 6.7% to $2.56 after gaining over 6% on Tuesday. The company, last month, posted a profit for its second quarter.

Check out these big penny stock gainers and losers


  • InnovAge Holding Corp. INNV shares dipped 24.3% to $8.82 after the company reported downbeat Q4 earnings and issued weak FY22 sales forecast.
  • ReWalk Robotics Ltd. RWLK fell 23.3% to $1.99 after climbing 99% on Tuesday.
  • Summit Therapeutics Inc. SMMT fell 22.7% to $5.01 after the company announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies.
  • Greenbrook TMS Inc. GBNH dipped 19.1% to $7.48. Greenbrook TMS announced plans to acquire Achieve TMS East, LLC and Achieve TMS Central, LLC. The company also reported a $10 million bought deal public offering.
  • Inotiv, Inc. NOTV dropped 17.8% to $41.02. Inotiv agreed to acquire Envigo RMS Holding Corp in a cash and stock transaction. The company also announced a proposed convertible senior notes offering.
  • Ensysce Biosciences, Inc. ENSC shares fell 13.9% to $3.92 after climbing 48% on Tuesday.
  • Airspan Networks Holdings Inc. MIMO dropped 12.6% to $7.20 after declining over 10% on Tuesday.
  • NanoViricides, Inc. NNVC dipped 12% to $5.45.
  • D8 Holdings Corp. RBOT dropped 11.4% to $12.87.
  • FibroGen, Inc. FGEN tumbled 11.4% to $9.95. Goldman Sachs downgraded FibroGen from Neutral to Sell and lowered the price target from $16 to $11.
  • BioDelivery Sciences International, Inc. BDSI dropped 10.8% to $3.5650. BioDelivery Sciences International expects its September quarter revenues to be in the range of $38 million to $42 million amid its ongoing legal tussle with Alvogen.
  • NeuroMetrix, Inc. NURO fell 10% to $11.93 after jumping over 26% on Tuesday.
  • FedEx Corporation FDX fell 8.6% to $230.30. FedEx reported weaker-than-expected earnings for its first quarter, while sales exceeded estimates. The company also lowered its guidance for FY21.
  • Adobe Inc. ADBE shares fell 3.4% to $624.28. Adobe reported upbeat earnings for its third quarter and issued strong forecast for the current quarter.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!